Effectiveness of oritavancin for management of skin and soft tissue infections in the emergency department: A case series
| Autor: | Drew Dretske, Brian Sharp, Michael S. Pulia, Lucas T Schulz, Erin Werner |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
Adult
Male medicine.medical_specialty medicine.drug_class Antibiotics Intravenous antibiotic therapy 03 medical and health sciences 0302 clinical medicine medicine Humans Infusions Intravenous Aged Retrospective Studies Aged 80 and over business.industry Soft Tissue Infections Oritavancin Lipoglycopeptides Soft tissue 030208 emergency & critical care medicine Cellulitis General Medicine Emergency department Middle Aged medicine.disease humanities Anti-Bacterial Agents Clinical trial Emergency medicine Emergency Medicine Vancomycin Female business Emergency Service Hospital medicine.drug |
| Zdroj: | The American journal of emergency medicine. 43 |
| ISSN: | 1532-8171 |
| Popis: | Skin and soft tissue infections, such as cellulitis, are commonly diagnosed in the emergency department and these patients are often admitted to the hospital for intravenous antibiotic therapy. Oritavancin is a novel antibiotic approved for the treatment of skin and soft tissue infections that is administered as a one-time infusion. While oritavancin has demonstrated comparable efficacy with multi-dose parenteral antibiotics in clinical trials and has been proposed as an alternative to admission for emergency department patients, there is a paucity of available real world effectiveness data. In this case series, we describe the characteristics and outcomes of ten patients with high-risk skin and soft tissue infections who received oritavancin and were discharged from the emergency department. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect